| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,059,216 | 1,083,312 | 1,050,282 | 991,011 | | Cost of Revenue | 530,716 | 705,332 | 367,008 | 831,012 | | | Gross Profit | 528,500 | 377,980 | 683,274 | 159,999 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 461,838 | 310,958 | 632,263 | 108,177 | | Non Recurring |
-
|
-
| (17,407) |
-
| | Others | 31,040 | 30,805 | 29,996 | 28,743 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,622 | 36,217 | 38,422 | 23,079 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,840) | 4,348 | 844 | (9,235) | | Earnings Before Interest And Taxes | 33,782 | 40,565 | 39,266 | 13,844 | | Interest Expense | 2,229 | 2,478 | 3,835 | 3,710 | | Income Before Tax | 31,553 | 38,087 | 35,431 | 10,134 | | Income Tax Expense | 13,027 | 15,734 | 13,638 | 2,772 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,526 | 22,353 | 21,793 | 7,362 | | | Non-recurring Events | | Discontinued Operations | (25,936) | 407 | (599) | (28,622) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,410) | 22,760 | 21,194 | (21,260) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,410) | $22,760 | $21,194 | ($21,260) |
|
0.20% Nasdaq 
Income Statement
